Fri, March 24, 2017
Thu, March 23, 2017
Wed, March 22, 2017

Liana Moussatos Reiterated (ASND) at Buy with Increased Target to $34 on, Mar 24th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-34-on-mar-24th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Liana Moussatos of Wedbush, Reiterated "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $31 to $34 on, Mar 24th, 2017.

Liana has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, March 9th, 2017


This is the rating of the analyst that currently disagrees with Liana


  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017